Search results
Results from the WOW.Com Content Network
Steatohepatitis. Micrograph of steatohepatitis. Liver biopsy using trichrome stain. Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.
The name "non-alcoholic steatohepatitis" (NASH) was later defined in 1980 by Jurgen Ludwig and his colleagues from the Mayo Clinic [146] to raise awareness of the existence of this pathology, as similar reports previously were dismissed as "patients' lies". [142]
Fatty liver disease (FLD), also known as hepatic steatosis and steatotic liver disease (SLD), is a condition where excess fat builds up in the liver. [1] Often there are no or few symptoms. [1][2] Occasionally there may be tiredness or pain in the upper right side of the abdomen. [1] Complications may include cirrhosis, liver cancer, and ...
Risk Factors for Fatty Liver Disease. Having overweight or obesity is a major risk factor for fatty liver disease. Estimates suggest that up to 75 percent of people with overweight have NAFLD, and ...
cytomegalovirus infection. herpesviral: herpes simplex infection. Toxoplasmosis. Hepatosplenic schistosomiasis. Portal hypertension in schistosomiasis. Liver disease in syphilis. Epstein–Barr virus infection. yellow fever virus infection. rubella virus infection.
Steatohepatitis is seen in both alcoholic and non-alcoholic liver disease and is the culmination of a cascade of events that began with injury. In the case of non-alcoholic steatohepatitis , this cascade is initiated by changes in metabolism associated with obesity, insulin resistance, and lipid dysregulation.
Resmetirom has been seen as a promising candidate for the treatment of nonalcoholic steatohepatitis (NASH) since its late-stage study in December helped reduce liver scarring or fibrosis in ...
From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Metabolic dysfunction–associated steatotic liver disease